BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 2735925)

  • 1. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.
    Ferrara N; Henzel WJ
    Biochem Biophys Res Commun; 1989 Jun; 161(2):851-8. PubMed ID: 2735925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
    Senger DR; Galli SJ; Dvorak AM; Perruzzi CA; Harvey VS; Dvorak HF
    Science; 1983 Feb; 219(4587):983-5. PubMed ID: 6823562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis: therapeutic implications.
    Folkman J
    N Engl J Med; 1971 Nov; 285(21):1182-6. PubMed ID: 4938153
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.
    Kim KJ; Li B; Winer J; Armanini M; Gillett N; Phillips HS; Ferrara N
    Nature; 1993 Apr; 362(6423):841-4. PubMed ID: 7683111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of vascular endothelial growth factor.
    Ferrara N; Davis-Smyth T
    Endocr Rev; 1997 Feb; 18(1):4-25. PubMed ID: 9034784
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
    Ferrara N; Carver-Moore K; Chen H; Dowd M; Lu L; O'Shea KS; Powell-Braxton L; Hillan KJ; Moore MW
    Nature; 1996 Apr; 380(6573):439-42. PubMed ID: 8602242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.
    Carmeliet P; Ferreira V; Breier G; Pollefeyt S; Kieckens L; Gertsenstein M; Fahrig M; Vandenhoeck A; Harpal K; Eberhardt C; Declercq C; Pawling J; Moons L; Collen D; Risau W; Nagy A
    Nature; 1996 Apr; 380(6573):435-9. PubMed ID: 8602241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in cancer, vascular, rheumatoid and other disease.
    Folkman J
    Nat Med; 1995 Jan; 1(1):27-31. PubMed ID: 7584949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a tumor factor responsible for angiogenesis.
    Folkman J; Merler E; Abernathy C; Williams G
    J Exp Med; 1971 Feb; 133(2):275-88. PubMed ID: 4332371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
    Dvorak HF; Brown LF; Detmar M; Dvorak AM
    Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
    Miller JW; Adamis AP; Shima DT; D'Amore PA; Moulton RS; O'Reilly MS; Folkman J; Dvorak HF; Brown LF; Berse B
    Am J Pathol; 1994 Sep; 145(3):574-84. PubMed ID: 7521577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF in Signaling and Disease: Beyond Discovery and Development.
    Apte RS; Chen DS; Ferrara N
    Cell; 2019 Mar; 176(6):1248-1264. PubMed ID: 30849371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
    Melincovici CS; Boşca AB; Şuşman S; Mărginean M; Mihu C; Istrate M; Moldovan IM; Roman AL; Mihu CM
    Rom J Morphol Embryol; 2018; 59(2):455-467. PubMed ID: 30173249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Intracrine Functions of VEGF-A.
    Wiszniak S; Schwarz Q
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33478167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of angiogenesis.
    Risau W
    Nature; 1997 Apr; 386(6626):671-4. PubMed ID: 9109485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model.
    Kimura T; Kato Y; Ozawa Y; Kodama K; Ito J; Ichikawa K; Yamada K; Hori Y; Tabata K; Takase K; Matsui J; Funahashi Y; Nomoto K
    Cancer Sci; 2018 Dec; 109(12):3993-4002. PubMed ID: 30447042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
    Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
    Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Relationship Between Vascular Smooth Muscle Cell Function and the Efficacy of Acupuncture in Treating Cerebral Ischemic Stroke: A Preclinical Meta-Analysis and Systematic Review.
    Cao JP; Du YH; Jia LY; Yin XM; Yang LH; Chen LL; Jiang T; Zhang M; Qiu T
    J Pain Res; 2024; 17():1693-1707. PubMed ID: 38746535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment.
    Cui S; Chen S; Wu X; Wang Q
    Front Neurosci; 2024; 18():1294417. PubMed ID: 38716256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research.
    Yu N; Aboud O
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.